- Home
- MIRA vs AMS Comparison
MIRA vs AMS Comparison
Compare MIRA & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- AMS
- Stock Information
- Founded
- MIRA 2020
- AMS 1980
- Country
- MIRA United States
- AMS United States
- Employees
- MIRA N/A
- AMS 13
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- MIRA Health Care
- AMS Health Care
- Exchange
- MIRA Nasdaq
- AMS Nasdaq
- Market Cap
- MIRA 18.4M
- AMS 19.3M
- IPO Year
- MIRA 2023
- AMS N/A
- Fundamental
- Price
- MIRA $1.10
- AMS $3.01
- Analyst Decision
- MIRA Strong Buy
- AMS
- Analyst Count
- MIRA 2
- AMS 0
- Target Price
- MIRA $14.00
- AMS N/A
- AVG Volume (30 Days)
- MIRA 226.5K
- AMS 4.3K
- Earning Date
- MIRA 03-31-2025
- AMS 03-26-2025
- Dividend Yield
- MIRA N/A
- AMS N/A
- EPS Growth
- MIRA N/A
- AMS 779.12
- EPS
- MIRA N/A
- AMS 0.61
- Revenue
- MIRA N/A
- AMS $24,969,000.00
- Revenue This Year
- MIRA N/A
- AMS $27.74
- Revenue Next Year
- MIRA N/A
- AMS $17.72
- P/E Ratio
- MIRA N/A
- AMS $4.96
- Revenue Growth
- MIRA N/A
- AMS 20.83
- 52 Week Low
- MIRA $0.51
- AMS $2.51
- 52 Week High
- MIRA $5.01
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- MIRA 43.36
- AMS 45.88
- Support Level
- MIRA $1.09
- AMS $2.88
- Resistance Level
- MIRA $1.18
- AMS $3.10
- Average True Range (ATR)
- MIRA 0.06
- AMS 0.06
- MACD
- MIRA -0.00
- AMS -0.01
- Stochastic Oscillator
- MIRA 7.69
- AMS 40.33
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.